Amanote Research
Register
Sign In
P1.01-107 the Impact of Anlotinib on Quality of Life in Patients With Advance NSCLC: Post-Hoc Analysis of a Phase III Randomized Control Trial (ALTER0303)
Journal of Thoracic Oncology
- United States
doi 10.1016/j.jtho.2018.08.664
Full Text
Open PDF
Abstract
Available in
full text
Categories
Medicine
Oncology
Respiratory Medicine
Pulmonary
Date
October 1, 2018
Authors
X. Si
L. Zhang
H. Wang
X. Zhang
M. Wang
B. Han
K. Li
Q. Wang
J. Shi
Z. Wang
Y. Cheng
J. He
Y. Shi
W. Chen
X. Wang
Y. Luo
K. Nan
F. Jin
B. Li
Y. Chen
J. Zhou
D. Wang
Publisher
Elsevier BV
Related search
P2.01-01 the Impact of Anlotinib on Brain Metastases of NSCLC: Post-Hoc Analysis of a Phase III Randomized Control Trial (ALTER0303)
Journal of Thoracic Oncology
Medicine
Oncology
Respiratory Medicine
Pulmonary
P3.01-084 Analysis on ALTER0303 Trial: ACECs Level May Correlate With Metastases Burden and Predict PFS of Anlotinib in Advanced NSCLC
Journal of Thoracic Oncology
Medicine
Oncology
Respiratory Medicine
Pulmonary
CRP/prealbumin, a Novel Inflammatory Index for Predicting Recurrence After Radical Resection in Gastric Cancer Patients: Post Hoc Analysis of a Randomized Phase III Trial
Gastric Cancer
Cancer Research
Medicine
Oncology
Gastroenterology
P1.01-106 Pembrolizumab Randomized, Phase 1 Study in Chinese Patients With Advanced NSCLC: KEYNOTE-032
Journal of Thoracic Oncology
Medicine
Oncology
Respiratory Medicine
Pulmonary
P1.01-98 a Phase IIIb Trial of Afatinib in EGFRm+ NSCLC: Analyses of Outcomes in Patients With Brain Metastases or Dose Reductions
Journal of Thoracic Oncology
Medicine
Oncology
Respiratory Medicine
Pulmonary
Effects of Physical Therapy on Quality of Life in Osteoporosis Patients - A Randomized Clinical Trial
Health and Quality of Life Outcomes
Medicine
Environmental
Public Health
Occupational Health
Effects of Vitamin D Optimization on Quality of Life of Patients With Fibromyalgia: A Randomized Controlled Trial
Medical Journal of the Islamic Republic of Iran
Medicine
The EORTC Module for Quality of Life in Patients With Thyroid Cancer: Phase III
Endocrine-Related Cancer
Cancer Research
Endocrinology
Oncology
Metabolism
Diabetes
P1.01-52 BR-34- Randomized Trial of Durvalumab and Tremelimumab +/- Platinum Chemotherapy in Patients With Metastatic Squamous or Non-Squamous NSCLC
Journal of Thoracic Oncology
Medicine
Oncology
Respiratory Medicine
Pulmonary